In MS, the secretion of AVP and CRH is closely related to the promotion of the disease and the co-expression of CRH/AVP in the hypothalamic neurons is higher in patients with MS than in the controls (Deckx et al., 2013). Here, CRH is linked to myeloid sarcoma.